Cita APA

Exman, P., Garrido-Castro, A. C., Hughes, M. E., Freedman, R. A., Li, T., Trippa, L., . . . Lin, N. U. (2019). Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials. JCO Precis Oncol.

Chicago Style Citation

Exman, Pedro, et al. "Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials." JCO Precis Oncol 2019.

Cita MLA

Exman, Pedro, et al. "Identifying ERBB2 Activating Mutations in HER2-Negative Breast Cancer: Clinical Impact of Institute-Wide Genomic Testing and Enrollment in Matched Therapy Trials." JCO Precis Oncol 2019.